tiprankstipranks
Ocular Therapeutix Inc (OCUL)
NASDAQ:OCUL
US Market
OCUL
Ocular Therapeutix
RESEARCH TOOLSreports
Want to see OCUL full AI Analyst Report?

Ocular Therapeutix (OCUL) Income Statement

1,587 Followers

Ocular Therapeutix Income Statement

Last quarter (Q4 2025), Ocular Therapeutix's total revenue was $13.25M, a decrease of -22.43% from the same quarter last year. In Q4, Ocular Therapeutix's net income was $-64.65M. See Ocular Therapeutix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 51.82M$ 63.72M$ 58.44M$ 51.49M$ 43.52M
Gross Profit
$ 45.25M$ 58.10M$ 53.16M$ 46.95M$ 39.12M
Operating Expenses
$ 315.39M$ 229.88M$ 135.54M$ 125.61M$ 117.15M
Depreciation and Amortization
$ 4.32M$ 3.79M$ 2.98M$ 2.11M$ 2.42M
EBITDA
$ -249.78M$ -176.14M$ -66.42M$ -61.91M$ 2.54M
Operating Income
$ -270.02M$ -171.78M$ -82.38M$ -78.65M$ -78.04M
Other Income/Expenses
$ 4.08M$ -21.73M$ 1.65M$ 7.62M$ 71.48M
Pretax Income
$ -265.94M$ -193.51M$ -80.74M$ -71.04M$ -6.55M
Net Income
$ -265.94M$ -193.51M$ -80.74M$ -71.04M$ -6.55M
Per Share Metrics
Basic EPS
$ -1.42$ -1.22$ -1.09$ -1.04$ -1.05
Diluted EPS
$ -1.42$ -1.22$ -1.02$ -0.97$ -0.98
Weighted Average Shares Outstanding
 187.24M 158.26M 79.83M 76.88M 76.39M
Weighted Average Shares Outstanding (Diluted)
 187.24M 158.26M 85.60M 82.64M 82.16M
Currency in USD

Ocular Therapeutix Earnings and Revenue History